Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine to relieve intrathecal morphine-induced pruritus after major laparoscopic surgery
ChiCTR2500108890Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of nalbuphine in pruritus (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Itching score. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
nalbuphine
03
Conditions
pruritus
Beyond the preview
Go deeper on ChiCTR2500108890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108890.